| - GRCh37:
- Chr1:100680396
- GRCh38:
- Chr1:100214840
| DBT | S306P | Maple syrup urine disease | Conflicting interpretations of pathogenicity (Oct 19, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:100672020
- GRCh38:
- Chr1:100206464
| DBT | T397I | Maple syrup urine disease type 2 | Uncertain significance (May 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:100680414
- GRCh38:
- Chr1:100214858
| DBT | A300fs | Maple syrup urine disease type 2 | Pathogenic (May 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:100680373
- GRCh38:
- Chr1:100214817
| DBT | K313N | not provided, Maple syrup urine disease, Maple syrup urine disease type 2
| Pathogenic/Likely pathogenic (Oct 4, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:100681641
- GRCh38:
- Chr1:100216085
| DBT | E224* | Maple syrup urine disease, Maple syrup urine disease type 2, not provided
| Pathogenic (May 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:100681730
- GRCh38:
- Chr1:100216174
| DBT | S194* | Maple syrup urine disease type 2 | Pathogenic (Apr 23, 2004) | no assertion criteria provided |
| - GRCh37:
- Chr1:100661376-100666120
- GRCh38:
- Chr1:100195820-100200564
| DBT | | Maple syrup urine disease type 2 | Pathogenic (Dec 1, 2003) | no assertion criteria provided |
| - GRCh37:
- Chr1:100706416-100706417
- GRCh38:
- Chr1:100240860-100240861
| DBT | C26fs | Maple syrup urine disease type 2, Maple syrup urine disease | Pathogenic/Likely pathogenic (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:100676249
- GRCh38:
- Chr1:100210693
| DBT | | Maple syrup urine disease type 2 | Pathogenic (Apr 1, 1991) | no assertion criteria provided |
| | DBT | | Maple syrup urine disease type 2 | Pathogenic (Feb 1, 1991) | no assertion criteria provided |